Silexion Therapeutics Corp
Filed Oct 9, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Oct 9, 2024
SLXN$0.15+1.0%Stored close · as of Nov 6, 2026
Contents
Statements of Operations
| Note | Year endedDecember 31,2023 | Year endedDecember 31,2022 | |
|---|---|---|---|
| U.S. Dollars | |||
| Except share data | |||
| Interest earned on investments held in trust account | 1,364,444 | 1,685,666 | |
| General and administrative | 9 | (1,122,480) | (1,232,342) |
| Change in fair value of Private Warrant liability | 21,109 | 130,701 | |
| Net profit for the year | 263,073 | 584,025 | |
| Weighted average number of Class A Ordinary Shares subject to Possible Redemption | 8 | 2,774,850 | 11,500,000 |
| Basic and diluted net profit per Class A Ordinary Shares subject to Possible Redemption | $0.51 | 0.07 | |
| Weighted average number of non-redeemable Class A and Class B Ordinary shares | 3,355,000 | 3,355,000 | |
| Basic and diluted net loss per non-redeemable Class A and Class B Ordinary shares | $(0.34) | (0.07) | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.